Getting your player ready...
WALNUT CREEK, Calif. — Longs Drug Stores Corp. on Tuesday repeated its refusal to enter buyout talks with Walgreen Co. or share information with its larger rival.
Longs said Walgreen “has not presented a clear road map to completion” of a deal and is not willing to assume any risk that the deal is rejected or delayed by antitrust regulators. Walgreen has offered to buy Longs for $75 a share, or $2.8 billion.
